RxDoctor Payments Data

Hannah Burkhart

Family · Hillsdale, MINPI 1689029829

Payments from drug & device makers

$987in general payments, 2019–2025

Across 69 payments — averaging $14.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$271
  • Lilly USA, LLC$175
  • Nestle Healthcare Nutrition Inc.$101
  • Johnson & Johnson$62
  • Pfizer$62
  • AstraZeneca$38
  • plus $279 from 14 others

What the payments were for

  • Food & beverage$97399%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$987 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$73,312
FarxigaDapagliflozin Propanediol64$66,466
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$50,896
JardianceEmpagliflozin40$44,167
JanuviaSitagliptin Phosphate42$43,064
RybelsusSemaglutide22$32,658
XareltoRivaroxaban41$25,510
MounjaroTirzepatide19$21,423
CaplytaLumateperone Tosylate11$21,159
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$17,096
MyrbetriqMirabegron11$12,388
EliquisApixaban13$11,946
Repatha SureclickEvolocumab12$10,728
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$6,571
Atrovent HfaIpratropium Bromide12$5,604

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$271$105,97080 claims
GSKTrelegy Ellipta, Anoro Ellipta$27$67,99276 claims
AstraZenecaFarxiga$38$66,46664 claims
Boehringer IngelheimJardiance, Stiolto Respimat$14$50,73851 claims
Johnson & JohnsonXarelto$62$25,51041 claims
Lilly USA, LLCMounjaro$175$21,42319 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$24$21,15911 claims
PfizerEliquis$62$11,94613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,657 family providers in Michigan.

Other family in Hillsdale

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →